139 related articles for article (PubMed ID: 1545393)
1. Evaluation of N-0861, (+-)-N6-endonorbornan-2-yl-9-methyladenine, as an A1 subtype-selective adenosine receptor antagonist in the guinea pig isolated heart.
Shryock JC; Travagli HC; Belardinelli L
J Pharmacol Exp Ther; 1992 Mar; 260(3):1292-9. PubMed ID: 1545393
[TBL] [Abstract][Full Text] [Related]
2. The cardiac effects of a novel A1-adenosine receptor agonist in guinea pig isolated heart.
Belardinelli L; Lu J; Dennis D; Martens J; Shryock JC
J Pharmacol Exp Ther; 1994 Dec; 271(3):1371-82. PubMed ID: 7996449
[TBL] [Abstract][Full Text] [Related]
3. (+-)-N6-endonorbornan-2-yl-9-methyladenine (N-0861) and its enantiomers: selective antagonists of A1-adenosine receptors in guinea pig isolated atria.
Martin PL; Potts AA; Sykes AM; McKenna DG
J Pharmacol Exp Ther; 1993 Apr; 265(1):201-6. PubMed ID: 8474007
[TBL] [Abstract][Full Text] [Related]
4. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
Belardinelli L; Shryock JC; Zhang Y; Scammells PJ; Olsson R; Dennis D; Milner P; Pfister J; Baker SP
J Pharmacol Exp Ther; 1995 Dec; 275(3):1167-76. PubMed ID: 8531078
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular effects of a non-xanthine-selective antagonist of the A1 adenosine receptor in the anaesthetised pig: pharmacological and therapeutic implications.
Sidi A; Wesley R; Barrett R; Rush W; Belardinelli L
Cardiovasc Res; 1994 May; 28(5):621-8. PubMed ID: 8025906
[TBL] [Abstract][Full Text] [Related]
6. 2-Phenylethoxy-9-methyladenine: an adenosine receptor antagonist that discriminates between A2 adenosine receptors in the aorta and the coronary vessels from the guinea pig.
Martin PL; Ueeda M; Olsson RA
J Pharmacol Exp Ther; 1993 Apr; 265(1):248-53. PubMed ID: 8474010
[TBL] [Abstract][Full Text] [Related]
7. Antagonism of the effects of adenosine and hypoxia on atrioventricular conduction time by two novel alkylxanthines: correlation with binding to adenosine A1 receptors.
Clemo HF; Bourassa A; Linden J; Belardinelli L
J Pharmacol Exp Ther; 1987 Aug; 242(2):478-84. PubMed ID: 3612546
[TBL] [Abstract][Full Text] [Related]
8. A novel irreversible antagonist of the A1-adenosine receptor.
Srinivas M; Shryock JC; Scammells PJ; Ruble J; Baker SP; Belardinelli L
Mol Pharmacol; 1996 Jul; 50(1):196-205. PubMed ID: 8700113
[TBL] [Abstract][Full Text] [Related]
9. Identification and functional characterization of A1 and A2 adenosine receptors in the rat vas deferens: a comparison with A1 receptors in guinea pig left atrium and A2 receptors in guinea pig aorta.
Martin PL; May JM
J Pharmacol Exp Ther; 1994 Jun; 269(3):1228-35. PubMed ID: 8014866
[TBL] [Abstract][Full Text] [Related]
10. Evidence that adenosine receptors in the dog left atrium are not of the typical A1 or A2 adenosine receptor subtypes.
Martin PL
Eur J Pharmacol; 1992 Apr; 214(2-3):199-205. PubMed ID: 1516639
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 8-(N-methylisopropyl)amino-N6-(5'-endohydroxy- endonorbornyl)-9-methyladenine (WRC-0571), a highly potent and selective, non-xanthine antagonist of A1 adenosine receptors.
Martin PL; Wysocki RJ; Barrett RJ; May JM; Linden J
J Pharmacol Exp Ther; 1996 Feb; 276(2):490-9. PubMed ID: 8632314
[TBL] [Abstract][Full Text] [Related]
12. Effect of adenosine on atrioventricular conduction. II: Modulation of atrioventricular node transmission by adenosine in hypoxic isolated guinea pig hearts.
Clemo HF; Belardinelli L
Circ Res; 1986 Oct; 59(4):437-46. PubMed ID: 3791584
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.
Barrett RJ; May JM; Martin PL; Miller JR
J Pharmacol Exp Ther; 1993 Apr; 265(1):227-36. PubMed ID: 8386236
[TBL] [Abstract][Full Text] [Related]
14. Effects of N6-endonorbornan-2-yl-9-methyladenine, N0861, on negative chronotropic and vasodilatory actions of adenosine in the canine heart in vivo.
Pelleg A; Hurt CM
Can J Physiol Pharmacol; 1992 Nov; 70(11):1450-6. PubMed ID: 1296857
[TBL] [Abstract][Full Text] [Related]
15. Selective potentiation by an A1 adenosine receptor enhancer of the negative dromotropic action of adenosine in the guinea pig heart.
Amoah-Apraku B; Xu J; Lu JY; Pelleg A; Bruns RF; Belardinelli L
J Pharmacol Exp Ther; 1993 Aug; 266(2):611-7. PubMed ID: 8355194
[TBL] [Abstract][Full Text] [Related]
16. Differential antagonism of cardiac actions of adenosine by theophylline.
Bertolet BD; Belardinelli L; Avasarala K; Calhoun WB; Franco EA; Nichols WW; Kerensky RA; Hill JA
Cardiovasc Res; 1996 Nov; 32(5):839-45. PubMed ID: 8944814
[TBL] [Abstract][Full Text] [Related]
17. Endogenous adenosine, A1 adenosine receptor, and pertussis toxin sensitive guanine nucleotide binding protein mediate hypoxia induced AV nodal conduction block in guinea pig heart in vivo.
Xu J; Tong H; Wang L; Hurt CM; Pelleg A
Cardiovasc Res; 1993 Jan; 27(1):134-40. PubMed ID: 8458024
[TBL] [Abstract][Full Text] [Related]
18. A comparison of an A1 adenosine receptor agonist (CVT-510) with diltiazem for slowing of AV nodal conduction in guinea-pig.
Snowdy S; Liang HX; Blackburn B; Lum R; Nelson M; Wang L; Pfister J; Sharma BP; Wolff A; Belardinelli L
Br J Pharmacol; 1999 Jan; 126(1):137-46. PubMed ID: 10051130
[TBL] [Abstract][Full Text] [Related]
19. Effect of adenosine on atrioventricular conduction. I: Site and characterization of adenosine action in the guinea pig atrioventricular node.
Clemo HF; Belardinelli L
Circ Res; 1986 Oct; 59(4):427-36. PubMed ID: 3791583
[TBL] [Abstract][Full Text] [Related]
20. Ischemic preconditioning prevents the impairment of hypoxic coronary vasodilatation caused by ischemia/reperfusion: role of adenosine A1/A3 and bradykinin B2 receptor activation.
Giannella E; Mochmann HC; Levi R
Circ Res; 1997 Sep; 81(3):415-22. PubMed ID: 9285644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
